En
Fr
(
Fr
)
Contact Us
Home
About Us
Our Company
Our strategy
Meet the Management Team
Our Board Members
Plasma Resources
Product pipeline
R&D Pipeline
PBI-4050
Alström Syndrome
Idiopathic Pulmonary Fibrosis
Selective GPR84 Antagonist
Selective OXER1 Antagonist
Plasminogen Deficiency
Scientific Posters
Investors & Media
Investor Resources
Press releases
Financial Reports
Webcasts
Stock information
SEC Filings
Corporate governance
Investor Briefcase
Frequently asked questions
Careers
Career Opportunities
Resume submission
Subscribe
Investor Resources
Investor Resources
Latest Content
Press Releases
Press Releases
Press Releases 2021
Press Releases 2020
Press Releases 2019
Financial Reports
Financial Reports
Financial Reports 2020
Financial Reports 2019
Financial Reports 2018
Corporate Documents
Corporate Documents
Corporate Governance Documentation
Scientific Posters
Videos & Webcasts
Videos & Webcasts
Our Technology
Alstrom Syndrome
Idiopathic Pulmonary Fibrosis (IPF)
Plasminogen Deficiency (PLGD)
Webcasts
×
Home
»
Corporate Governance Documentation
»
Code of Ethics and Business Conduct 2020
×
Share this Presentation
Facebook
Twitter
Email
LinkedIn
Code of Ethics and Business Conduct 2020
Share this Flipbook
Facebook
Twitter
Email
LinkedIn
Previous Flipbook
CEO Position Description 2020
Next Flipbook
Liminal BioSciences Articles of Incorporation 2019
Prometic Life Sciences Inc. articles of incorporation and articles of amendments
Most Recent Flipbooks
‹
›
Majority Voting Policy 2020
Read PDF
Board Committees - Chairs' Mandate 2020
Read PDF
Position Description Lead Independent Director 2020
Read PDF
Certificate of Amendment - October 3, 2019
Read PDF
Articles of Amendment - June 16, 2020
Read PDF
Certificate of Amendment - January 25, 2013
Read PDF
Certificate of Amendment - November 13, 2018
Read PDF
Certificate of Amendment - June 28, 2019
Read PDF
Certificate of Amendment - June 1, 2017
Read PDF
Certificate of Amendment - May 15, 2008
Read PDF
Certificate of Amendment - February 16, 2000
Read PDF
Restated Articles of Incorporation - May 19, 1998
Read PDF
Amendment to By-Law No.1 - June 8, 2020
Read PDF
By-Law No.3
Read PDF
By-Law No.2
Read PDF
Amendment to By-Law No.1 - May 3, 2006
Read PDF
By-Law No.1
Read PDF
Board of Directors Charter 2020
Read PDF
Mandate of the Chair of the Board 2020
Read PDF
CEO Position Description 2020
Read PDF
Return to Home
×
Streams
Latest Content
Press Releases
Press Releases 2021
Press Releases 2020
Press Releases 2019
Financial Reports
Financial Reports 2020
Financial Reports 2019
Financial Reports 2018
Corporate Documents
Corporate Governance Documentation
Scientific Posters
Videos & Webcasts
Our Technology
Alstrom Syndrome
Idiopathic Pulmonary Fibrosis (IPF)
Plasminogen Deficiency (PLGD)
Webcasts
Share this Hub
Facebook
Twitter
Email
LinkedIn
×
